首页> 外文期刊>Advances in Pharmacology and Pharmacy >A Retrospective Analysis of Antipsychotic Medication Use with Concomitant Clinical Evaluation in Outpatient Psychiatry Department in Palestine
【24h】

A Retrospective Analysis of Antipsychotic Medication Use with Concomitant Clinical Evaluation in Outpatient Psychiatry Department in Palestine

机译:巴勒斯坦门诊精神科的抗精神病药物使用回顾性分析及其临床评估

获取原文
       

摘要

Objectives: The objective of this paper was to study antipsychotic medication use in the outpatient psychiatry department in Palestine. Methodology: This is a cross sectional study carried out in Palestine on schizophrenic patients aged between 20 – 65 whose medications have not been changed in the past six months and they did not have an acute attack in the last year. Information regarding antipsychotic medications use was obtained from patients’ medical files; patients’ psychiatric symptoms were evaluated using the Expanded Brief Psychiatric Rating Scale (BPRS-E).Results: More than half (53.1%) of 150 patients were on antipsychotic polypharmacy (APP) with average daily dose of 546.9 ± 254.9 mg chlorpromazine equivalents. The average number (mean ± SD) of medications a patient received was 1.7 ± 0.7. One third of patients on APP regimen received atypical antipsychotic and all of them received at least one conventional antipsychotic. Factors significantly and positively associated with APP were: use of anticholinergic agents (P<0.001), conventional antipsychotics (P<0.001), depot formulations (P<0.001) and prescribing higher doses of antipsychotics (P<0.001). Discussion and Conclusion: Antipsychotic polypharmacy in this study was common. Adherence to international guidelines in the treatment of schizophrenia is recommended.
机译:目的:本文的目的是研究巴勒斯坦门诊精神病科的抗精神病药物使用情况。方法:这是在巴勒斯坦针对20至65岁的精神分裂症患者进行的一项横断面研究,这些患者在过去六个月内未更换药物并且在去年没有急性发作。有关抗精神病药物使用的信息是从患者的医疗档案中获得的;结果:在150例患者中,有一半以上(53.1%)接受了抗精神病药房(APP),平均每日剂量为546.9±254.9 mg氯丙嗪当量。患者接受药物治疗的平均次数(平均值±标准差)为1.7±0.7。接受APP疗法的患者中有三分之一接受了非典型的抗精神病药物治疗,所有患者均接受了至少一种常规的抗精神病药物治疗。与APP显着正相关的因素是:使用抗胆碱药(P <0.001),常规抗精神病药(P <0.001),长效制剂(P <0.001)以及开较大剂量的抗精神病药(P <0.001)。讨论与结论:抗精神病药房在这项研究中很普遍。建议在精神分裂症治疗中遵循国际准则。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号